Self-catalytic antibodies for the efficient production of antibody-drug conjugates (Self-ADC)

• Unité de recherche: INNOSUISSE
• Numéro de projet: 125.905 IP-LS
• Titre du projet anglais: Self-catalytic antibodies for the efficient production of antibody-drug conjugates (Self-ADC)

Mots-clé (Anglais)

Life sciences, Biotechnology and processing

Résumé des résultats (Abstract) (Anglais)

Self-ADC proposes a novel approach to antibody-drug conjugate production. It simplifies antibody bioconjugation without complex chemistry or costly enzymes. Multidisciplinary in essence, Self-ADC combines protein engineering with antibody production, synthetic chemistry, and biomolecular analytics.